Increased pentosidine, an advanced glycation end-product, in urine and tissue reflects disease activity in inflammatory bowel diseases

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue SUPPL. 2, 2008, Pages

  Kato, Shingo ^a   Itoh, Kazuro ^b   Ochiai, Mitsuko ^a   Iwai, Atsuhiro ^b   Park, Yeongji ^c   Hata, Satoshi ^c   Takeuchi, Kyoko ^b   Ito, Masataka ^b   Imaki, Junko ^b   Miura, Soichiro ^b   Yakabi, Koji ^a   Kobayashi, Makio ^d  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c Section of Surgery   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Advanced glycation end product; ELISA; Inflammatory bowel disease; Pentosidine; Ulcerative colitis; Urine

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; PENTOSIDINE;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CROHN DISEASE; DIABETES MELLITUS; DISEASE ACTIVITY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MALE; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; ULCERATIVE COLITIS;

EID: 57449084706     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05552.x     Document Type: Conference Paper

References (26)

1. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 1988 318 : 1315 21.
2. Sugiyama S, Miyata T, Ueda Y et al. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J. Am. Soc. Nephrol. 1998 9 : 1681 8.
3. Weiss M, Rodby RA, Justice AC, Hricik DE. Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group. Kidney Int. 1998 54 : 193 202.
4. Tsukahara H, Sekine K, Uchiyama M et al. Formation of advanced glycation end products and oxidative stress in young patients with type 1 diabetes. Pediatr. Res. 2003 54 : 419 24.
5. Daimon M, Sugiyama K, Kameda W et al. Increased urinary levels of pentosidine, pyraline and acrolein adduct in type 2 diabetes. Endocr. J. 2003 50 : 61 7.
6. Miyata T, Ueda Y, Shinzato T et al. Accumulation of albumin-linked and free form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathogenesis of pentosidine. J. Am. Soc. Nephrol. 1996 7 : 1198 206.
7. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996 49 : 1304 13.
8. Miyata T, Wada Y, Cai Z et al. Implication of an increased oxidative stress in the formation of advanced glycation end products in the patients with end-stage renal failure. Kidney Int. 1997 51 : 1170 81.
9. Takahashi M, Suzuki M, Kushida K, Miyasato S, Inoue T. Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis. Br. J. Rheumatol. 1997 36 : 637 42.
10. Miyata T, Ishiguro N, Yasuda Y et al. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Biochem. Biophys. Res. Commun. 1998 244 : 45 9.
11. Chen JR, Takahashi M, Suzuki M, Kushida K, Miyamoto S, Inoue T. Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis. J. Rheumatol. 1998 25 : 2440 4.
12. Chen JR, Takahashi M, Suzuki M, Kushida K, Miyamoto S, Inoue T. Comparison of the concentration of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis. Rheumatology 1999 38 : 1275 8.
13. Miyata T, Kurokawa K, Van Ypersele de Strihou C. Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J. Am. Soc. Nephrol. 2000 11 : 1744 52.
14. Babbs CF. Oxygen radicals in ulcerative colitis. Free Radic. Biol. Med. 1992 13 : 169 81.
15. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N. Engl. J. Med. 1987 317 : 1625 9.
16. Winship DH, Summers RW, Singleton JW et al. National Cooperative Crohn's disease study: study design and conduct of the study. Gastroenterology 1979 77 : 829 42.
17. Matts SGF. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q. J. Med. 1961 120 : 393 407.
18. Sanaka T, Funaki T, Tanaka T et al. Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure. Nephron 2002 91 : 64 73.
19. Horie K, Miyata T, Maeda K et al. Immunohistochemical colonization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions: Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J. Clin. Invest. 1997 100 : 2995 3004.
20. Suzuki D, Miyata T, Saotome N et al. Immunohistochemical evidence for an increased oxidative stress and carboxyl modification of proteins in diabetic glomerular lesions. J. Am. Soc. Nephrol. 1999 10 : 822 32.
21. Kouda K, Nakamura H, Fan W, Horiuchi K, Takeuchi H. The relationship of oxidative DNA damage marker 8-hyroxyguanosine and glycoxidation damage marker pentosidine. Clin. Biochem. 2001 34 : 247 50.
22. Pertynska-Marczewska M, Kiriakidis S, Wait R, Beech J, Feldmann M, Paleolog EM. Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages. Cytokine 2004 28 : 35 47.
23. Rouhiainen A, Kuja-Panula J, Wilkman E et al. Regulation of monocyte migration by amphoterin (HMGB1). Blood 2004 104 : 1174 82.
24. Ge J, Jia Q, Liang C et al. Advanced glycocylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells. Arterioscler. Thromb. Vasc. Biol. 2005 25 : 2157 63.
25. Takahashi M, Kushida K, Ishihara C, Denda M, Inoue T. Plasma pentosidine levels in uremic patients before and after hemodialysis. Scand. J. Urol. Nephrol. 1995 29 : 131 4.
26. Monnier VM. Nonenzymatic glycosylation, the Maillard and the aging process. J. Gerontol. 1990 45 : B105 11.